MAX BioPharma has exclusively licensed the small molecule oxysterols from University of California, Los Angeles and Johns Hopkins University in the US. The pharmaceutical company has also received a Small Business Innovation Research ...
CardioLogical Solutions, a cardiovascular device company, has reported successful in vivo validation of its VasoStitch device, designed to make transcatheter aortic valve implantation (TAVI) procedures percutaneous and safer. The ...
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, cin its SIMPLE Antibody research program collaboration with Shire Pharmaceuticals' Human Genetic Therapies division. The milestone, which was the first ...
US-based DiscoveRx’s BioSeek division launched BioMAP panel, a primary human cell-based assay platform, for oncology research. The BioMAP panel comprising primary human cell-based tumor-host model systems allows the researchers to ...
Tags: Oncology Research, Biomap Panel
SeaChange Pharmaceuticals has introduced its similarity ensemble approach (SEA) software called SEAware for predictive matching of drugs with disease and toxicity targets. SEAware provides analysis and visualization tools for prediction ...
US-based biotechnology company Veritas Bio received a patent related to in vivo delivery of nucleic acids from the European Patent Office. Inventor Dr Pachuk noted the allowed claims cover transfecting nucleic acids into skin or muscle ...
The European Commission has granted marketing authorization for Teva Pharmaceutical Industries' Lonquex (lipegfilgrastim) to commercialize in all twenty eight countries of the European Union plus Norway, Iceland and Liechtenstein. ...
KU Leuven and FIT Biotech have reached a global license and partnership agreement for the development of novel immunotherapeutics leveraging FIT Biotech's gene transport unit (GTU) technology for transient in vivo expression of monoclonal ...
The Alzheimer's Drug Discovery Foundation (ADDF) has funded Madera Biosciences with a sum of $298,500 to advance the development of the company’s small molecule drugs. The drugs are intended to clear the accumulated beta-amyloid ...
Tags: Molecule Drugs, Medicine
US-based inhaled medicines provider Genoa Pharmaceuticals in collaboration with McMaster University has demonstrated advantages of the inhaled aerosol pirfenidone (GP-101) in the treatment of pulmonary fibrosis. The findings showed that ...
Tags: Genoa, Mcmaster University
DiFusion, a US-based medical device firm focused on surgical site infections in orthopedic and spine surgery, has completed a series of in vitro tests and an in vivo study at Clemson University to validate the efficacy of its new ...
Bitter oranges (Citrus aurantium L.) are very popular in Northwest Africa where they gently perfume the ryhads (private gardens in traditional Moroccan homes) while providing shade to inhabitants. Naturex has built up a network of pickers ...
Tags: Bitter Orange Flower, Skin
San Carlos, California, United States of America (Free-Press-Release.com) May 7, 2013 -- Rosa & Co. LLC today announced that Dr. Michael A. Eldon, Principal Scientific Fellow, VP, Clinical Pharmacology, Nektar Therapeutics, will present a ...
The Chinese State Food and Drug Administration (SFDA) has approved Symrise’s SymWhite 377 as an ingredient for cosmetic applications. Sponsored Links Acute Pain Management Training Official suppliers of NHS Acute Pain Management ...
Tags: Whitening Ingredient, Daily Use
Ablynx has commenced pre-clinical development of ALX-0962, an anti- immunoglobulin E (IgE) nanobody, to treat severe allergic asthma and expects to begin Phase I development in the second half of 2014. ALX-0962 comprises anti-IgE Nanobody ...
Tags: Ablynx, Pre-Clinical Development